Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Study findings from Mayo Clinic provide new insights into vaccines
December 24th, 2008
"The next 'golden age' in vaccinology will be ushered in by the new science of vaccinomics. in turn, this will inform and allow the development of personalized vaccines, based on our increasing understanding of immune response phenotype: genotype information," investigators in the United States report. "Rapid advances in developing such data are already occurring for hepatitis B, influenza, measles, mumps, rubella, anthrax and smallpox vaccines. In addition, newly available data suggest that some vaccine-related adverse events may also be genetically determined and, therefore, predictable," wrote G.A. Poland and colleagues, Mayo Clinic. The...
Source: Vaccine Weekly (2008-12-24)
|
